Ion Beam Applications Inkomsten in het verleden
Verleden criteriumcontroles 2/6
Ion Beam Applications's earnings have been declining at an average annual rate of -32.3%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 9.3% per year. Ion Beam Applications's return on equity is 8.7%, and it has net margins of 1.7%.
Belangrijke informatie
-32.3%
Groei van de winst
-32.3%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 12.3% |
| Inkomstengroei | 9.3% |
| Rendement op eigen vermogen | 8.7% |
| Nettomarge | 1.7% |
| Volgende winstupdate | 21 Nov 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Ion Beam Applications SA (EBR:IBAB) Shares Fly 25% But Investors Aren't Buying For Growth
Oct 08
Is Now An Opportune Moment To Examine Ion Beam Applications SA (EBR:IBAB)?
Sep 19It's Unlikely That The CEO Of Ion Beam Applications SA (EBR:IBAB) Will See A Huge Pay Rise This Year
Jun 06Further Upside For Ion Beam Applications SA (EBR:IBAB) Shares Could Introduce Price Risks After 29% Bounce
Mar 25Is Ion Beam Applications (EBR:IBAB) Using Too Much Debt?
Nov 07Ion Beam Applications (EBR:IBAB) Has Some Way To Go To Become A Multi-Bagger
Oct 05Ion Beam Applications (EBR:IBAB) Is Investing Its Capital With Increasing Efficiency
Jan 31Is Ion Beam Applications (EBR:IBAB) A Risky Investment?
Sep 28Here's Why Shareholders May Want To Be Cautious With Increasing Ion Beam Applications SA's (EBR:IBAB) CEO Pay Packet
Jun 01Ion Beam Applications' (EBR:IBAB) Returns On Capital Are Heading Higher
May 29Does Ion Beam Applications SA (EBR:IBAB) Have A Place In Your Dividend Stock Portfolio?
Apr 20Is Ion Beam Applications (EBR:IBAB) A Risky Investment?
Mar 30Should You Use Ion Beam Applications' (EBR:IBAB) Statutory Earnings To Analyse It?
Feb 10What Type Of Shareholders Make Up Ion Beam Applications SA's (EBR:IBAB) Share Registry?
Jan 06Does This Valuation Of Ion Beam Applications SA (EBR:IBAB) Imply Investors Are Overpaying?
Dec 10Ion Beam Applications' (EBR:IBAB) Shareholders Are Down 64% On Their Shares
Nov 17
Ion Beam Applications SA (EBR:IBAB) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?
Aug 20Estimating The Intrinsic Value Of Ion Beam Applications SA (EBR:IBAB)
Jul 21Opbrengsten en kosten
Hoe Ion Beam Applications geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 466 | 8 | 82 | 51 |
| 31 Mar 24 | 447 | -1 | 81 | 49 |
| 31 Dec 23 | 429 | -9 | 80 | 48 |
| 30 Sep 23 | 400 | -14 | 78 | 47 |
| 30 Jun 23 | 371 | -19 | 77 | 46 |
| 31 Mar 23 | 366 | -7 | 75 | 44 |
| 31 Dec 22 | 361 | 6 | 74 | 42 |
| 30 Sep 22 | 349 | 5 | 71 | 40 |
| 30 Jun 22 | 336 | 4 | 69 | 39 |
| 31 Mar 22 | 324 | 4 | 65 | 36 |
| 31 Dec 21 | 313 | 4 | 60 | 34 |
| 30 Sep 21 | 326 | 23 | 61 | 33 |
| 30 Jun 21 | 339 | 42 | 61 | 33 |
| 31 Mar 21 | 326 | 37 | 61 | 33 |
| 31 Dec 20 | 312 | 32 | 61 | 33 |
| 30 Sep 20 | 288 | 16 | 61 | 32 |
| 30 Jun 20 | 264 | 1 | 61 | 31 |
| 31 Mar 20 | 273 | 4 | 62 | 31 |
| 31 Dec 19 | 283 | 8 | 62 | 31 |
| 30 Sep 19 | 325 | 5 | 74 | 38 |
| 30 Jun 19 | 295 | -2 | 67 | 34 |
| 31 Mar 19 | 276 | -3 | 64 | 31 |
| 01 Jan 19 | 257 | -4 | 61 | 28 |
| 30 Sep 18 | 229 | -25 | 58 | 26 |
| 30 Jun 18 | 175 | -45 | 45 | 21 |
| 31 Mar 18 | 206 | -43 | 51 | 24 |
| 31 Dec 17 | 236 | -42 | 57 | 27 |
| 30 Sep 17 | 311 | -14 | 73 | 34 |
| 30 Jun 17 | 335 | 12 | 73 | 33 |
| 31 Mar 17 | 332 | 18 | 71 | 33 |
| 31 Dec 16 | 329 | 25 | 70 | 32 |
| 30 Sep 16 | 312 | 40 | 67 | 31 |
| 30 Jun 16 | 294 | 55 | 64 | 30 |
| 31 Mar 16 | 282 | 58 | 61 | 28 |
| 01 Jan 16 | 270 | 61 | 58 | 27 |
| 01 Oct 15 | 257 | 46 | 56 | 27 |
| 30 Jun 15 | 243 | 31 | 54 | 27 |
| 31 Mar 15 | 232 | 26 | 53 | 25 |
| 31 Dec 14 | 221 | 21 | 51 | 23 |
| 30 Sep 14 | 217 | 9 | 49 | 23 |
| 30 Jun 14 | 213 | -2 | 49 | 23 |
| 31 Mar 14 | 213 | -3 | 48 | 23 |
| 31 Dec 13 | 213 | -4 | 48 | 23 |
Kwaliteitswinsten: IBAB has a large one-off loss of €4.4M impacting its last 12 months of financial results to 30th June, 2024.
Groeiende winstmarge: IBAB became profitable in the past.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: IBAB has become profitable over the past 5 years, growing earnings by -32.3% per year.
Versnelling van de groei: IBAB has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Winst versus industrie: IBAB has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.7%).
Rendement op eigen vermogen
Hoge ROE: IBAB's Return on Equity (8.7%) is considered low.